Immutep Limited Asset Turnover Ratio (IMMP), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Immutep Limited  (NASDAQ: IMMP)
 

Immutep Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Immutep Limited asset turnover ratio, the ability of Immutep Limited's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.07 in the fourth quarter (Jun 30 2025), yet the ratio remained below the average, as IMMP's position remain challenging.

Within sector 5 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2025, to 149, from total ranking in the third quarter 2025 at 2243.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMMP Asset Turnover Ratio (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Asset Change -21.68 % -21.68 % -23.12 % -21.68 % 45.68 %
Y / Y Revenue Change 31.8 % - - - 50.74 %
Asset Turnover Ratio (TTM) 0.07 - - - 0.04
IMMP's Total Ranking # 149 # 2243 # # #
Seq. Asset Change 0 % 52.05 % -34.23 % -21.68 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 16
Overall Market # 149

Asset Turnover Ratio Statistics
High Average Low
88.58 23.8 2.06
(Jun 30 2025)   (Jun 30 2023)




IMMP Company Profile • Back to IMMP Efficiency Comparisons • Compare IMMP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
Sintx Technologies Inc   0.18 $ 1.861  Millions$ 10.340  Millions
Harvard Apparatus Regenerative Technology Inc   0.18 $ 0.679  Millions$ 3.826  Millions
Petvivo Holdings Inc   0.18 $ 0.986  Millions$ 5.633  Millions
Arbutus Biopharma Corp  0.17 $ 15.416  Millions$ 88.151  Millions
Ginkgo Bioworks Holdings Inc   0.17 $ 230.815  Millions$ 1,345.701  Millions
Traws Pharma inc   0.17 $ 2.903  Millions$ 17.146  Millions
Zomedica Corp   0.17 $ 28.979  Millions$ 175.235  Millions
Surrozen Inc   0.16 $ 12.621  Millions$ 78.497  Millions
Entrada Therapeutics Inc   0.16 $ 79.476  Millions$ 504.043  Millions
Xencor Inc  0.16 $ 146.929  Millions$ 933.991  Millions
Xilio Therapeutics Inc   0.16 $ 15.001  Millions$ 95.816  Millions
Immunitybio inc   0.16 $ 56.600  Millions$ 363.335  Millions
Vystar Corporation  0.15 $ 0.085  Millions$ 0.550  Millions
Inspiremd Inc   0.15 $ 6.488  Millions$ 42.326  Millions
Meiragtx Holdings Plc  0.15 $ 37.917  Millions$ 247.992  Millions
Maxcyte inc   0.15 $ 35.753  Millions$ 234.448  Millions
Legend Biotech Corporation  0.15 $ 255.058  Millions$ 1,677.897  Millions
Eyepoint Inc   0.15 $ 51.898  Millions$ 345.773  Millions
Semler Scientific inc   0.15 $ 42.978  Millions$ 287.016  Millions
Nurix Therapeutics Inc   0.15 $ 88.381  Millions$ 597.385  Millions
Igc Pharma Inc   0.14 $ 1.327  Millions$ 9.240  Millions
Pacific Biosciences Of California Inc   0.14 $ 155.375  Millions$ 1,099.190  Millions
Lipella Pharmaceuticals Inc   0.14 $ 0.470  Millions$ 3.353  Millions
Lucid Diagnostics Inc   0.14 $ 4.360  Millions$ 31.195  Millions
Humacyte Inc   0.14 $ 19.243  Millions$ 138.496  Millions
Insmed Inc  0.14 $ 288.663  Millions$ 2,090.199  Millions
Silence Therapeutics Plc  0.14 $ 27.169  Millions$ 196.944  Millions
Femasys Inc   0.14 $ 1.887  Millions$ 13.772  Millions
Sage Therapeutics Inc   0.14 $ 70.410  Millions$ 515.561  Millions
Editas Medicine Inc   0.14 $ 38.902  Millions$ 285.847  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.